Current Situation of Postoperative Adjuvant Chemoradiotherapy for Extrahepatic Cholangiocarcinoma
10.3971/j.issn.1000-8578.2023.22.0677
- VernacularTitle:肝外胆管癌术后辅助放化疗的现况分析
- Author:
Xiao YANG
1
;
Hui PENG
;
Liang ZHUANG
Author Information
1. Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China
- Publication Type:Research Article
- Keywords:
Extrahepatic cholangiocarcinoma;
Adjuvant chemotherapy;
Adjuvant radiotherapy;
Adjuvant chemoradiotherapy
- From:
Cancer Research on Prevention and Treatment
2023;50(1):81-85
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the incidence of extrahepatic cholangiocarcinoma (ECC) has been increasing annually. As a result of frequently invading adjacent structures, such as hepatic artery, hepatic vein, and portal vein, and low radical resection rate, the prognosis is poor. Even if radical resection is completed early, the 5-year survival rate is still less than 30%. At present, whether postoperative adjuvant therapy can improve the prognosis of ECC remains a research hotspot and a controversial point. This article will combine the latest research results to discuss the plan and status of postoperative adjuvant therapy after ECC, as well as analyze the effect of postoperative adjuvant therapy on ECC.
